Search results

Why more caution is needed in administering QT prolonging drugs to type 1 diabetic patients.
www.richmondresearchinstitute.org/news/why-more-caution-is-needed-in-administering-qt-prolonging-drugs-to-type-1-diabetic-patients

Why more caution is needed in administering QT prolonging drugs to type 1 diabetic patients. Diabetes. Cardiac. 3rd March 2021. 400,000 people are currently living with type 1 diabetes in the UK, one of the highest rates in the world.

News - Richmond Research Institute
www.richmondresearchinstitute.org/news

Diabetes. RRI study finds antimalaria drug has no negative impact on cardiac safety in healthy volunteers.

Projects [2022]
www.richmondresearchinstitute.org/dev/projects-2022

Considering the risk of QTc prolongation in patients with diabetes mellitus. View publication. Effect of hyperglycaemia in combination with moxifloxacin on cardiac repolarization in male and female patients with type I diabetes. View publication.

Research - Richmond Research Institute
www.richmondresearchinstitute.org/research

Current studies. 12.061: Type I diabetes monitoring and QTc interval. Diabetes mellitus (DM) is a common metabolic disorder characterised by high blood glucose. It is caused by a lack of pancreatic beta-cell insulin production in type 1 DM.

Dr Dominic Pimenta wins the 'Young Investigators Award for Primary Care and Risk Factor Management'
www.richmondresearchinstitute.org/news/dr-dominic-pimenta-wins-the-young-investigators-award-for-primary-care-and-risk-factor-management

Diabetes. 12th April 2022. We are delighted to confirm that RRI's Lead Specialty Research Physician, Dominic Pimenta, has won the Young Investigators Award at the. ESC Preventive Cardiology 2022.

Publications [2022]
www.richmondresearchinstitute.org/dev/publications-2022

Considering the risk of QTc prolongation in patients with diabetes mellitus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Richmond Research Institute
www.richmondresearchinstitute.org/projects/12-061-type-i-diabetes-monitoring-and-qtc-interval

Current studies. 12.061: Type I diabetes monitoring and QTc interval. Diabetes mellitus (DM) is a common metabolic disorder characterised by high blood glucose. It is caused by a lack of pancreatic beta-cell insulin production in type 1 DM.

RRI study finds antimalaria drug has no negative impact on cardiac safety in healthy volunteers
www.richmondresearchinstitute.org/news/rri-study-finds-antimalaria-drug-has-no-negative-impact-on-cardiac-safety-in-healthy-volunteers

Diabetes. RRI Lead Specialty Research Physician wins award for Cardiovascular risk factor analysis of data associated with UK grocery brand Tescos. Phase I study confirms cardiac safety of potential alopecia treatment. Cardiac. Phase I.

Cardiac Health - Richmond Research Institute
www.richmondresearchinstitute.org/research/cardiac-health

Jorg Taubel’s. research examines the effects of cardiac ion channel-blocking drugs on ventricular repolarization delay in healthy individuals and those with diabetes type I and type II. Dr.

Richmond Research Institute
www.richmondresearchinstitute.org/projects/21-026-telemonitoring-in-cardiac-amyloidosis-pathway-rct

Current studies. 12.061: Type I diabetes monitoring and QTc interval. Diabetes mellitus (DM) is a common metabolic disorder characterised by high blood glucose. It is caused by a lack of pancreatic beta-cell insulin production in type 1 DM.

We work with partners at the following organisations: 

richmond research institute

We have a track record in conducting clinical research.

Publications

We present our scientific findings at meetings.

Videos

Our academic research helps improve lives and strengthens scientific insights.

Research